Farmaceutica Remedia SA RMAH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 93.70M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 20.35
- Price/Sales
- 0.09
- Dividend Yield (Trailing)
- 6.87%
- Dividend Yield (Forward)
- 6.87%
- Dividend Payment Schedule
- Sep
- Total Yield
- 7.70%
Company Profile
Farmaceutica Remedia SA is engaged in drug sales activities, marketing, and health products. It provides marketing and promotion services for medicines. The company offers services offered, including logistics services, medical marketing, and promotion, and pharmaceutical registrations, but also professionalism and performance differentiate the company from other competitors and position it as a partner for launching, promoting, and distributing pharmaceutical products in Romania and other countries in Eastern Europe.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Small Value
- Total Number of Employees
- 210
- Website
- https://corporate.remedia.ro
Valuation
|
Metric
|
RMAH
|
|---|---|
Price/Earnings (Normalized) | 20.35 |
Price/Book Value | 0.93 |
Price/Sales | 0.09 |
Price/Cash Flow | 81.90 |
Price/Earnings
RMAH
Financial Strength
|
Metric
|
RMAH
|
|---|---|
Quick Ratio | 0.91 |
Current Ratio | 1.10 |
Interest Coverage | — |
Quick Ratio
RMAH
Profitability
|
Metric
|
RMAH
|
|---|---|
Return on Assets (Normalized) | 0.94% |
Return on Equity (Normalized) | 4.47% |
Return on Invested Capital (Normalized) | 2.74% |
Return on Assets
RMAH
Medical Distribution Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| McKesson Corp
MCK
| LOCK|Fp<f^sM | LOCK|#?g@ | $107B | |||
| Cencora Inc
COR
| LOCK|ZpTfM&q | LOCK|h<%c | $60B | |||
| Cardinal Health Inc
CAH
| LOCK|SR@J@R | LOCK|%pqS^ | $54B | |||
| Sigma Healthcare Ltd
SIGGF
| — | LOCK|#tvQ | $21B | |||
| Henry Schein Inc
HSIC
| LOCK|h@<#cWc | LOCK|PT%m? | $9B | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR
SHPMY
| — | LOCK|^G | $8B | |||
| Sinopharm Group Co Ltd
SHTDF
| — | LOCK|@QN | $6B | |||
| Sinopharm Group Co Ltd ADR
SHTDY
| — | LOCK|<& | $6B | |||
| Galenica Ltd
GALNF
| — | LOCK|c&$f | $5B | |||
| Medipal Holdings Corp
MEPDF
| — | LOCK|##v | $4B |
United States